PreprintCited by 21Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency

Open access

Preprint — published as 10.1073/pnas.2425781122 · Paper page

Abstract

Bispecific T-cell engagers (TcEs) link T cell receptors to tumor-associated antigens on cancer cells, forming cytotoxic immunological synapses (IS). Close membrane-to-membrane contact (≤13 nm) has been proposed as a key mechanism of TcE function. To investigate this and identify potential additional mechanisms, we compared four immunoglobulin G1-based (IgG1) TcE Formats (A-D) targeting CD3ε and Her2, designed to create varying intermembrane distances (A<B<C<D). Small-angle X-ray scattering (SAXS) and modelling of the conformational states of isolated TcEs and TcE-antigen complexes predicted close-contacts (≤13 nm) for Formats A and B and far-contacts (≥18 nm) for Formats C and D. In supported lipid bilayer (SLB) model interfaces, Formats A and B recruited, whereas Formats C and D repelled, CD2-CD58 interactions. Formats A and B also excluded bulky Quantum dots more effectively. SAXS also revealed that TcE-antigen complexes formed by Formats A and C were less flexible than complexes formed by Formats B and D. Functional data with Her2-expressing tumor cells showed cytotoxicity, surface marker expression and cytokine release following the order A>B=C>D. In a minimal system for IS formation on SLBs, TcE performance followed the trend A=B=C>D. Addition of close-contact requiring CD58 co-stimulation revealed phospholipase C-γ activation matching cytotoxicity with A>B=C>D. Our findings suggest that, when adhesion is equivalent, TcE potency is determined by two parameters: contact distance and flexibility. Both the close/far-contact formation axis and the low/high flexibility axis significantly impact TcE potency, explaining the similar potency of Format B (close-contact/high flexibility) and C (far-contact/low flexibility). Significance statement: Bispecific T-cell engagers (TcEs) are immunotherapeutic drugs that trigger the destruction of cancer cells by linking T cells to cancer cell through specific surface molecules (antigens). We designed a series of TcEs with varying distances between their binding sites and flexibilities of the TcE-antigen complexes. By combining structural and functional analyses, we confirmed close-contact formation between T cells and cancer cells as a critical determinant, mediated by co-activating receptors. Furthermore, we also identified molecular flexibility of the TcE-antigen complex as a further critical parameter for TcE potency. These findings provide novel insights into TcE function and highlight the importance of both parameters for future research and the design of improved immunotherapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.06.15.496334

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 75

  1. 10.1016/S0140-6736(23)00521-4 · DOI
  2. 10.1080/19420862.2016.1268307 · DOI
  3. 2020, Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy, Front. Cell Dev. Biol, 7, 1
  4. 10.1016/j.csbj.2020.05.006 · DOI
  5. 10.4049/jimmunol.1900496 · DOI
  6. 10.1016/j.ymeth.2018.10.026 · DOI
  7. 10.7554/eLife.82978 · DOI
  8. 10.1126/scitranslmed.aay2857 · DOI · Paper page
  9. 10.1158/2326-6066.CIR-14-0161 · DOI · Paper page
  10. 10.1016/S1074-7613(01)00234-5 · DOI
  11. 10.1038/s41590-020-0770-x · DOI
  12. 10.1016/j.jsb.2009.05.007 · DOI
  13. 10.1038/nri2887 · DOI
  14. 10.1016/j.cell.2017.03.006 · DOI
  15. 10.1016/j.cell.2008.09.044 · DOI
  16. A. L. Lanz , et al., Allosteric activation of T cell antigen receptor signaling by quaternary structure relaxation. Cell Rep. 36 (2021). · DOI
  17. 10.1016/j.cell.2014.02.053 · DOI
  18. 10.1016/j.cell.2018.06.017 · DOI
  19. 10.1126/scisignal.2001902 · DOI
  20. 10.1038/nature03843 · DOI
  21. 10.1038/ni1369 · DOI
  22. 10.1038/s41565-018-0113-3 · DOI
  23. 10.1182/bloodadvances.2019001188 · DOI
  24. 10.1073/pnas.1719905115 · DOI
  25. 10.1007/s00262-010-0844-y · DOI
  26. 10.1016/j.ccell.2017.02.001 · DOI
  27. 2021, One size does not fit all: navigating the multi-dimensional space to optimize T-cell engaging protein therapeutics, MAbs, 13, 1
  28. 10.1016/j.bbrc.2018.08.064 · DOI
  29. 10.1146/annurev.biophys.37.032807.125829 · DOI
  30. S. Pessano , H. Oettgent , A. K. Bhan , The T3/T cell receptor complex: antigenic distinction between the two 20-kd T3 (T3-6 and T3-E) subunits. 4, 337–344 (1985). · DOI
  31. 10.1038/s41598-021-04080-3 · DOI
  32. 10.1371/journal.pone.0016163 · DOI
  33. 10.1038/s41598-019-40055-1 · DOI
  34. 10.3402/NANO.V6.25661 · DOI
  35. 10.1074/jbc.M804756200 · DOI
  36. 10.1016/j.febslet.2015.08.027 · DOI
  37. E. Jenkins , et al., Reconstitution of immune cell interactions in free-standing membranes. J. Cell Sci. 132 (2019). · DOI
  38. 10.1016/0167-5699(96)80617-7 · DOI
  39. 10.1038/s41598-018-23276-8 · DOI
  40. 10.1039/c3tb20904k · DOI
  41. J. Middelburg , et al., Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors. Cancers (Basel ). 13 (2021). · DOI
  42. 10.1186/s12967-015-0680-0 · DOI
  43. 10.1189/jlb.0603298 · DOI
  44. 10.1172/JCI200419337 · DOI
  45. 10.1016/j.molimm.2005.03.007 · DOI · Paper page
  46. L. R. Díaz , et al., Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma. JCI insight 3 (2018). · DOI
  47. 10.1016/j.ymthe.2018.01.020 · DOI
  48. 10.1093/intimm/dxl141 · DOI
  49. J. Burton , et al., Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors. Proc. Natl. Acad. Sci. 120 (2023). · DOI
  50. 10.1136/jitc-2022-004759 · DOI
  51. 10.1016/j.csbj.2020.05.006 · DOI
  52. 10.1016/j.immuni.2024.01.007 · DOI
  53. 10.1038/s41467-024-45766-2 · DOI · Paper page
  54. 10.1038/346425a0 · DOI · Paper page
  55. 10.1038/s41467-023-36855-9 · DOI
  56. 10.1126/sciimmunol.abm3723 · DOI
  57. 10.1073/pnas.0510991103 · DOI
  58. M. Fritzsche , K. Kruse , Mechanical force matters in early T cell activation. 121, 1–9 (2024). · DOI
  59. 10.1002/prot.25485 · DOI
  60. 10.1158/1078-0432.CCR-20-2845 · DOI
  61. 10.1126/science.aaz9356 · DOI
  62. 10.1038/s41408-021-00430-6 · DOI · Paper page
  63. L. L. Sun , et al., Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies. Sci. Transl. Med. 7 (2015). · DOI
  64. 10.1016/S2352-3026(22)00072-2 · DOI · Paper page
  65. 10.6004/jadpro.2023.14.2.7 · DOI
  66. 10.1182/blood-2022-159586 · DOI
  67. 10.1158/1078-0432.CCR-18-0455 · DOI
  68. 10.1038/nbt.2621 · DOI
  69. 10.1107/S1600577520009960 · DOI
  70. 10.1093/nar/gkw389 · DOI
  71. 10.1002/jcc.20084 · DOI
  72. 10.1107/S0907444910007493 · DOI · Paper page
  73. 10.1016/0263-7855(96)00018-5 · DOI · Paper page
  74. 2007, Supported planar bilayers for study of the immunological synapse, Curr. Protoc. Immunol., 18, 1
  75. 10.1016/j.biomaterials.2022.121522 · DOI

Metadata

Authors
Leithner, A., Staufer, O., Mitra, T., Liberta, F., Valvo, S., Kutuzov, M., Dada, H., Spaeth, J., Zhou, S., Schiele, F., Reindl, S., Nar, H., Hoerer, S., Crames, M., Comeau, S., Young, D., Low, S., Jenkins, E., Davis, S. J., Klenerman, D., Nixon, A., Pefaur, N., Wyatt, D., Dushek, O., Kasturirangan, S., & Dustin, M. L.
Affiliations
  • University of Oxford (GB)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Boehringer Ingelheim (Germany) (DE)
  • Boehringer Ingelheim (United States) (US)
  • John Radcliffe Hospital (GB)
  • University of Cambridge (GB)
Corresponding author
  • Leithner, Alexander
  • Staufer, Oskar
  • Mitra, Tanmay
  • Liberta, Falk
  • Dustin, Michael L.
Venue
Proceedings of the National Academy of Sciences
Publisher
openRxiv
Published
2022-06-17
Volume
122
Issue
22
Pages
e2425781122-e2425781122
ISSN
0027-8424 (ISSN-L)
OpenAlex
W4410889835
Cited by
21
References
1
Citations by year
2026: 14 · 2025: 5 · 2024: 2
FWCI
10.90
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
Funders
  • Joachim Herz Stiftung
  • Wellcome Trust (2018-I2M-2-002, 207537/Z/Z17/Z, 207537)
  • Diamond Light Source
  • UK Research and Innovation (BB/X015408/1)
  • Kennedy Trust for Rheumatology Research (KENN202117)
  • University of Oxford
  • Austrian Science Fund (J4542-B)
  • Chinese Academy of Medical Sciences (2018‐I2M‐2‐002)
  • Directorate for Biological Sciences
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council (BB/X015408/1)
  • Leibniz-Gemeinschaft
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
bispecific T-cell engagers, immunological synapse, intermembrane distance, CD3ε, HER2, T cell cytotoxicity, protein flexibility, cancer immunotherapy
MeSH terms
Humans, Immunoglobulin G, Lipid Bilayers, Receptors, Antigen, T-Cell, T-Lymphocytes, X-Ray Diffraction, CD3 Complex, Antibodies, Bispecific, Erb-b2 Receptor Tyrosine Kinases, Cell Line, Tumor, Scattering, Small Angle, Immunological Synapses

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review